Corrigendum: Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis - Rodríguez-Jorge, Fernando; Fernández-Velasco, José Ignacio; Villarrubia, Noelia; Gracia-Gil, Julia; Fernández, Eva; Meca-Lallana, Virginia; Díaz-Pérez, Carolina; Sainz de la Maza, Susana; Pacheco, Eva María; Quiroga, Ana; Ramió-Torrentà, Lluis; Martínez-Yélamos, Sergio; et al. (Frontiers in Immunology, 2024)